구독하기
연구 모델
서비스
전임상 효능 평가
Resource
FVB-hHTT Q150 KI Mouse
제품 견적 요청
카탈로그에서 제품을 선택하여 요청을 제출해 주세요. Cyagen 팀이 상세 정보를 제공해 드립니다.
FVB-hHTT Q150 KI Mouse
제품명
FVB-hHTT Q150 KI Mouse
제품 ID
C001874
품종 계통
FVB/NJCya-Httem1(hHTT*Q150)/Cya
Backgroud
FVB/NJCya
상태
이 마우스 계통을 논문에서 사용할 경우, “FVB-hHTT Q150 KI Mouse (카탈로그 번호 C001874)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
Other Target Humanized Mouse Models
Disease Animal Models
Neurodegenerative Diseases
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
가격 문의
Other Target Humanized Mouse Models
Disease Animal Models
Neurodegenerative Diseases
기본 정보
검증 데이터
관련 자료
기본 정보
유전자명
유전자 별칭
HD, IT15, LOMARS
NCBI ID
염색체
Chr 4
MGI ID
Datasheet
품종 계통 설명
Huntingtin (HTT) is a disease-associated gene widely expressed in various tissues and organs, including the central nervous system, and is essential for normal development. The coding region of the HTT gene contains a polymorphic trinucleotide (cytosine-adenine-guanine, CAG) repeat sequence near its 5' end, which forms a polyglutamine (polyQ) tract during translation. Huntington's disease is a neurodegenerative disorder characterized by the loss of striatal neurons, caused by the aberrant expression of the CAG repeat sequence in the HTT gene. When the CAG repeat is expanded beyond 35 copies, it leads to abnormal polyQ expansion, resulting in incorrect folding of HTT protein fragments, dysregulation of protein-protein interactions, and accumulation in the cell nucleus and neuronal terminals, ultimately affecting neural signaling, intracellular protein transport, and mitochondrial function [1]. Currently, there are no effective drugs or methods to prevent or treat Huntington's disease, and there is a great need for further research into its mechanisms and the development of therapeutic approaches [2].
This strain is an hHTT Q150 knock-in mouse model generated by gene editing technology, in which a mutated human HTT gene sequence carrying 150 CAG repeats is inserted into the mouse genome. Literature reports have shown that these mice exhibit pathological features and functional impairments characteristic of Huntington's disease, and are suitable for developing and screening therapeutic drugs for Huntington's disease and safety evaluation [3]. The heterozygous FVB-hHTT Q150 KI mice are viable and fertile.
Reference
Walker FO. Huntington's disease. Lancet. 2007 Jan 20;369(9557):218-28.
McColgan P, Tabrizi SJ. Huntington's disease: a clinical review. Eur J Neurol. 2018 Jan;25(1):24-34.
Crook ZR, Housman D. Huntington's disease: can mice lead the way to treatment? Neuron. 2011 Feb 10;69(3):423-35.
변형 전략
A mutated human HTT gene sequence carrying 150 CAG repeats was knocked into the mouse Htt gene Exon 1.

Figure 1. Gene editing strategy of FVB-hHTT Q150 KI mice.
응용 분야
Development and screening of therapeutic drugs for Huntington's disease;
Evaluation of therapeutic drug efficacy and safety for Huntington's disease;
Research on the pathogenesis of Huntington's disease.
검증 데이터
1. Gene Expression

Figure 2. Detection of gene expression in the cerebellum, cerebral cortex, hippocampus, and striatum of FVB-hHTT Q150 KI mice and wild-type (WT) mice (8-week-old, heterozygous, female, n=3). RT-qPCR results showed that after humanization of exon 1, the RNA transcription of the murine Htt (mHtt) gene showed a relatively obvious downward trend in the cerebellum and cerebral cortex; however, no significant changes were observed in the hippocampus and striatum. (Data are presented as Mean ± SD)
2. Behavioral Testing: Grip Strength Test
(1)2-month-old
Indications:
No significant alterations in force across all models.

Figure 3. The force for WT and FVB-hHTT Q150 KI mice in the grip strength test. Data were analyzed using unpaired t-test; "ns" indicates no significant differences.
(2)3-month-old
Indications:
No significant alterations in force across all models.

Figure 4. The force for WT and FVB-hHTT Q150 KI mice in the grip strength test. Data were analyzed using unpaired t-test; "ns" indicates no significant differences.
(3)6-month-old
Indications:
Compared to WT mice, male FVB-hHTT Q150 KI exhibited a significant reduction in grip force, suggesting muscle function impairments. In contrast, female and mixed-sex FVB-hHTT Q150 KI showed no significant changes.

Figure 5. Grip strength measurements of FVB-hHTT Q150 KI mice at six months of age. Statistical comparisons were performed using either an unpaired t-test or Welch’s t-test, depending on variance equality. “ns” indicates no statistically significant difference; *p < 0.05.
3. Behavioral Testing: Open Field Test
(1)2-month-old: Travel Distance & Central Area Time Ratio
Indications:
(A-C) No significant alterations in travel distance across all models.
(D-F) For female and sex-mixed comparisons, FVB-hHTT Q150 KI exhibited a significant rise in the central time ratio. This may suggest increased activity levels in HTT mice compared to WT controls, as similar behavioral patterns have been documented in other Cyagen mouse models of hyperactivity. It could also imply that the HTT mice are experiencing cognitive impairment, given that spatial differentiation is a component of cognitive functions, and mice typically avoid traveling in the central area of the open field arena, which is reflected in the WT control behavioral pattern. Both types of abnormalities (hyperactivity and cognitive impairments) have been noted in previous studies on HTT mouse models (Shenoy et al., 2022) [4].

Figure 6. The travel distance (A-C) and central area time ratio (D-F) for WT and FVB-hHTT Q150 KI mice in open field test. Data were analyzed using unpaired t-test; "ns" indicates no significant differences, **p < 0.01, ***p < 0.001.
(2)2-month-old: Central Speed & Peripheral Speed
Indications:
(A-C) No significant alterations in central speed across all models.
(D-F) No significant alterations in peripheral speed across all models.

Figure 7. The central speed (A-C) and peripheral speed (D-F) for WT and FVB-hHTT Q150 KI mice in the open field test. Data were analyzed using unpaired t-test; "ns" indicates no significant differences.
(3)3-month-old: Travel Distance & Central Area Time Ratio
Indications:
(A-C) No significant alterations in travel distance across all models.
(D-F) For female and sex-mixed comparisons, FVB-hHTT Q150 KI exhibited a significant rise in the central time ratio. This may suggest increased activity levels in HTT mice compared to WT controls, as similar behavioral patterns have been documented in other Cyagen mouse models of hyperactivity. It could also imply that the HTT mice are experiencing cognitive impairment, given that spatial differentiation is a component of cognitive functions, and mice typically avoid traveling in the central area of the open field arena, which is reflected in the WT control behavioral pattern. Both types of abnormalities (hyperactivity and cognitive impairments) have been noted in previous studies on HTT mouse models (Shenoy et al., 2022) [4].

Figure 8. The travel distance (A-C) and central area time ratio (D-F) for WT and FVB-hHTT Q150 KI mice in open field test. Data were analyzed using unpaired t-test; "ns" indicates no significant differences, **p < 0.01, ***p < 0.001.
(4)3-month-old: Central Speed & Peripheral Speed
Indications:
(A-C) For the female comparison, FVB-hHTT Q150 KI exhibited a significant decrease in central speed.
(D-F) For the sex-mixed comparison, FVB-hHTT Q150 KI exhibited a significant decrease in peripheral speed.

Figure 9. The central speed (A-C) and peripheral speed (D-F) for WT and FVB-hHTT Q150 KI mice in the open field test. Data were analyzed using unpaired t-test; "ns" indicates no significant differences.
(5)6-month-old: Travel Distance & Central Area Time Ratio
Indications:
(A~C): In both male and mixed-sex groups, FVB-hHTT Q150 KI mice exhibited a clear decreasing trend in travel distance, suggesting impaired spontaneous locomotor activity.
(D~F): Compared to WT mice, FVB-hHTT Q150 KI mice showed a significant reduction in the central time ratio across sexes, indicative of anxiety-like behavior.

Figure 10. The travel distance (A-C) and central area time ratio (D-F) for WT and FVB-hHTT Q150 KI mice in open field test. (A~C): Travel distance of FVB-hHTT Q150 KI mice in the open field test measured over 10 minutes. Statistical comparisons were conducted using unpaired t-test; "ns" indicates no significant differences, *p<0.05. (D~F): Time ratio spent in the central area of the open field arena (central area time/total time) for FVB-hHTT Q150 KI mice at six months of age, measured over 10 minutes. Statistical comparisons were conducted using unpaired t-test; *p<0.05.
(6)6-month-old: Central Speed & Peripheral Speed
Indications:
No significant differences in movement speed were observed between FVB-hHTT Q150 KI and WT mice.

Figure 11. The central speed (A-C) and peripheral speed (D-F) for WT and FVB-hHTT Q150 KI mice in the open field test. (A~C): Central speed (mm/s) of FVB-hHTT Q150 KI mice at six months of age measured over 10 minutes in the open field arena. Statistical comparisons were conducted using unpaired t-test; "ns" indicates no significant differences. (D~F): Peripheral speed (mm/s) of FVB-hHTT Q150 KI mice at six months of age measured over 10 minutes in the open field arena. Statistical comparisons were conducted using unpaired t-test; "ns" indicates no significant differences, *p<0.05.
4. Behavioral Testing: Rotarod Test
(1)3-month-old
Indications:
Compared to WT, FVB-hHTT Q150 KI showed a significant decrease in latency, regardless of sex or sex-mixed comparisons, indicating impairments in locomotor activity and coordination.

Figure 12. The latency for WT and FVB-hHTT Q150 KI mice in rotarod test. Data were analyzed using unpaired t-test; "ns" indicates no significant differences, **p < 0.01, ***p < 0.001, ****p < 0.0001.
(2)6-month-old
Indications:
FVB-hHTT Q150 KI demonstrated a significant decrease in latency to fall compared to WT mice, regardless of sex or mixed-sex comparisons, indicating deficits in locomotor activity and coordination.

Figure 13. Latency to fall in FVB-hHTT Q150 KI mice at six months of age during the rotarod test. Statistical comparisons were performed using either an unpaired t-test or Welch’s t-test, depending on variance equality. “ns” indicates no statistically significant difference; **p < 0.01, ****p < 0.0001.
5. Grip strength, rotarod, and open field test (14-month-old)
Compared to WT mice, both male and female FVB-hHTT Q150 KI mice exhibited decreased grip strength and reduced latency on the rotarod, indicating impaired locomotor activity and coordination.
Additionally, the reduction in distance traveled and the percentage of time spent in the center further confirm deficits in locomotor activity and an increase in anxiety levels.

Figure 14. The grip strength, rotarod, and open field analysis of FVB-hHTT Q150 KI mice at 14 months.
문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
